Bear,

Correct me if I am wrong, but is now the Primary MACE rate has  changed to 6.9 per 100 patient years which is a drop of 1.1 per 100 years in the past year.   If you think that management has a good indication of the # of patient years the BETONMACE trial is currently at, than RVX  they should know if the trial is taking longer than it should normally have been, I wonder if that information is past on to signifcant stake holder and insiders such as Hepalink , Dart, Thir eye etc.  It could bode well for the trial....